Molly Purser

@mollypurser_HE

Health Economist at RTI-HS

Vrijeme pridruživanja: kolovoz 2017.

Tweetovi

Blokirali ste korisnika/cu @mollypurser_HE

Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @mollypurser_HE

  1. 5. ruj 2019.

    Great to see this innovation and cooperation! ⁩ Cigna Health Services Business Pioneers an Innovative Solution to Affordably Bring Life-Changing Therapies to Patients | BioSpace

    Poništi
  2. 20. svi 2019.

    Rare disease modeling considerations from Chris Knight : disease complexity, clinical benefit, patient and caregiver burden

    Poništi
  3. 20. svi 2019.

    Looking forward the the rare diseases Educational Symposium!

    Poništi
  4. 9. velj 2019.
    Poništi
  5. Poništi
  6. 24. sij 2019.

    Statement from FDA Commissioner Scott Gottlieb, M.D. and Peter Marks, M.D., Ph.D., Director of the Center for Biologics Evaluation and Research on new policies to advance development of safe and effective cell and gene therapies

    Poništi
  7. 14. stu 2018.
    Poništi
  8. 14. stu 2018.

    Wonderful session to end . Great to hear a payer perspective, especially on indication-based pricing for Would like to see this type of panel in New Orleans

    Poništi
  9. 13. stu 2018.

    More potentially therapies are in the pipeline, great to hear this discussion. Potential differences in the therapies and therapeutic area may result in different answers to these questions.

    Poništi
  10. 13. stu 2018.

    @JensGrueger provided great points on valuing a cure vs a chronic treatment at spotlight session

    Poništi
  11. 13. stu 2018.

    Great discussion at on expanding the Precision/Personalized Medicine SIG to include

    Poništi
  12. 12. stu 2018.

    Presenting our poster this morning @ISPORBarcelona on a regenerative medicine classification for HEOR

    Poništi
  13. 19. lis 2018.

    Looking forward to the ISPOR Summit today on value assessment

    Poništi
  14. 17. lis 2018.

    Economic model estimated reduction in hospital costs was a main driver

    Poništi
  15. 13. lis 2018.
    Poništi
  16. 12. lis 2018.

    Great news for these patients. Looking forward to following the progress of this novel

    Poništi
  17. 5. lis 2018.

    Interesting presentation by @AliBrivanlou on how self-organizing synthetic embryos may one day cure Huntington’s disease at thhe last day of the Alliance for Regenerative Medicine conf

    Poništi
  18. proslijedio/la je Tweet

    News from the nest! The European Medicines Agency () has accepted our marketing authorization application for our investigational gene therapy:

    Poništi
  19. 4. lis 2018.

    Agree! Reimbursement strategy needs to be considered early to ensure these transformative therapies get the patients.

    Poništi
  20. 4. lis 2018.

    Dr. Oz Azam highlights the importance of having a health economic and HTA strategy early in the development of and products.

    Poništi

Čini se da učitavanje traje već neko vrijeme.

Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.

    Možda bi vam se svidjelo i ovo:

    ·